 Noble Financial reaffirmed their buy rating on shares of Dyadic International NASDAQ:DYAI in a research note published on Monday, TipRanks reports. Noble Financial currently has a 11.00 price objective on the biotechnology companys stock. Separately, ValuEngine raised shares of Dyadic International from a sell rating to a hold rating in a research report on Wednesday, ... 